ZeroStack Corp. Common Stock (ZSTK) is a publicly traded the market company. As of July 9, 2026, ZSTK trades at $2.52 with a market cap of $7.83M and a P/E ratio of -0.07. ZSTK moved +0.00% today. Year to date, ZSTK is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.69 to $15.04. Rallies surfaces ZSTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ZeroStack Subsidiary Secures US$14.7M Pharmaceutical Inventory Orders in Germany: ZeroStack’s German subsidiary Phatebo secured purchase orders worth up to US$14.7 million (EUR 12.9 million) of pharmaceutical inventory from two German companies. Fulfillment hinges on obtaining inventory financing facilities, which if secured, could drive recurring revenue and strengthen ZeroStack’s European distribution platform.
| Metric | Value |
|---|---|
| Price | $2.52 |
| Market Cap | $7.83M |
| P/E Ratio | -0.07 |
| EPS | $-39.92 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.04 |
| 52-Week Low | $2.69 |
| Volume | 215.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $41.17M |
| Net Income | $-155.63M |
| Gross Margin | 15.72% |
ZSTK analyst coverage data. Average price target: $0.00.